Department: Market Access

Director, Market Access


The Director, Market Access will be responsible for implementation of market interventions and will play a key role in increasing access to and adoption of new TB regimens in low- and middle-income countries especially those with high incidence of tuberculosis. Through market understanding and implementing access strategies, the Director, Market Access will contribute to broad access, availability, and rapid and successful introduction of improved TB treatments, working at both a global and country level. 

The position is very broad in scope, with involvement in both market research and implementation of high impact initiatives, both with technical, global health collaborators and commercial partners. Market access at the TB Alliance includes all elements on the value chain including manufacturing, pricing, forecasting, procurement, and regulatory issues as well as technical adoption-related issues such as policy, market understanding, and diagnostics. 

The opening is happening at an exciting time for new TB regimens. Regulatory approval for the novel, short, all-oral regimen for XDR-TB is expected in August 2019, and work is ongoing to support planning for a forthcoming short regimen for both DS and MDR-TB. 

Position description:

  • Help develop strategies to support broad access, availability and adoption of forthcoming TB regimens.
  • Ensure TB Alliance has contemporary and in-depth understanding of the TB market and sub-segments, to drive adoption and uptake of new TB regimens, through market research and market intelligence
  • Design, guide and coordinate market research to support and inform policy development, global launch planning and market uptake initiatives
  • Design and conduct implementation research in target countries to guide development of local initiative to catalyze access to novel TB regimens
  • Lead coordination for design and implementation of in-country and regional access initiatives in collaboration with local agencies, technical partners, commercial partners and stakeholders such as WHO, USAID, regulators, etc.
  • Serve as focal point for the TB Alliance in a range of priority countries for collaboration with partners and local agencies
  • Develop proposals for donor financing of access initiatives
  • Responsible for compliance with applicable GxP regulations in performing the functions of the job, including attendance at annual GxP or other applicable regulatory trainings provided by TB Alliance.

Ideal candidates will have:

  • 10+ years’ professional experience in product or service development and launch in emerging markets and developing countries. Experience with a pharmaceutical company, global health initiative or other related sector. Working knowledge of public health systems and private health care treatment in countries with high incidence of tuberculosis.
  • Experience designing primary qualitative and quantitative market research, selecting, commissioning, and overseeing externally conducted research, and experience with resourceful utilization of secondary research to solve challenging business or public health issues.
  • Relevant educational background; MBA, MPH or other relevant advanced degree desirable.
  • Ability to absorb and synthesize a broad range of information, especially clinical and scientific information.
  • Ability to think strategically, handle ambiguity, problem solve, collaborate with a small team, and work across several projects concurrently.
  • Excellent project management, communication and analytical skills.
  • Strong business savvy.
  • Drive to succeed and results orientation.
  • Commitment to global health and neglected diseases, specifically TB.


New York, NY



To apply for this position, send resumes and cover letters to Please include the position title in the subject line.

Organizational Information:

TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.

With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website:

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio